Tianjin Chase Sun Pharmaceutical Co.,Ltd

Shenzhen Stock Exchange:300026.SZ

Location

Market Cap

USD 1.66 B

Share Price

USD 0.55

Avg Daily Volume

63,022,064

Change (1 day)

-0.71%

Change (1 year)

32.47%

Change (YTD)

6.72%

Tianjin Chase Sun Pharmaceutical Co.,Ltd Operating Income Margin for the year ending December 31, 2024: 0.61%

Tianjin Chase Sun Pharmaceutical Co.,Ltd Operating Income Margin is 0.61% for the year ending December 31, 2024, a -92.42% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Tianjin Chase Sun Pharmaceutical Co.,Ltd Operating Income Margin for the year ending December 31, 2023 was 8.09%, a -24.54% change year over year.
  • Tianjin Chase Sun Pharmaceutical Co.,Ltd Operating Income Margin for the year ending December 31, 2022 was 10.71%, a -6.09% change year over year.
  • Tianjin Chase Sun Pharmaceutical Co.,Ltd Operating Income Margin for the year ending December 31, 2021 was 11.41%, a 13.17% change year over year.
  • Tianjin Chase Sun Pharmaceutical Co.,Ltd Operating Income Margin for the year ending December 31, 2020 was 10.08%, a 4.37% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin